HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population.

Abstract
Genomic rearrangement occasionally affects the BRCA1/2 genes in Caucasian breast cancer patients. However, the incidence of BRCA1/2 genomic rearrangement in Asians, including the Korean population, has not been well established. Here, we investigated the contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer patients in this population. We screened for BRCA1/2 genomic rearrangement using multiplex ligation-dependent probe amplification for 122 high-risk breast cancer patients who tested negative for BRCA1/2 mutations. A novel deletion of exons 13-15 in BRCA1 was identified in one patient (0.8% occurrence frequency). Further analyses revealed that this c.4186-1593_4676-1465del might be the result of homologous recombination mediated by two Alu-elements: the AluY in intron 12, and an AluSp in intron 15. This result suggests that subsequent screening for BRCA1/2 genomic rearrangements should be considered in high-risk Korean breast cancer patients who test negative for BRCA1/2 mutations. BRCA1/2 genomic rearrangement, however, is likely to make only a small contribution to breast cancer in this population.
AuthorsMoon-Woo Seong, Sung Im Cho, Dong-Young Noh, Wonshik Han, Sung-Won Kim, Chul-Min Park, Hyun-Woong Park, So Yeon Kim, Ji Yeon Kim, Sung Sup Park
JournalFamilial cancer (Fam Cancer) Vol. 8 Issue 4 Pg. 505-8 ( 2009) ISSN: 1573-7292 [Electronic] Netherlands
PMID19669600 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Asian People (genetics)
  • Base Sequence
  • Breast Neoplasms (genetics)
  • Female
  • Gene Rearrangement
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetic Predisposition to Disease
  • Humans
  • Korea
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: